← United States · Coverage record
US · SEC FORM 4
Caris Life Sciences, Inc.
CAI · Nasdaq · CIK 0002019410 · Healthcare · Biotechnology
INSIDER SIGNAL
2 qualifying P purchase groups
in the current 180-day scoring window
25 Form 4 transaction lines observed in the same window
5 sales · 18 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 9 additional owner(s) remain in Form 4 evidence.
Purchase breadth & concentration
Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-05-15 · HALBERT JON.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 13,891,975
- Previous report
- 13,331,431
- Avg daily volume
- 5,592,020
- Days to cover
- 2.5
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | HALBERT JON | Purchase (P) | Common Stock | 68,000 | USD 14.56 | USD 990,080 | SEC filing ↗ |
| 2026-05-11 | Vacirca Jeff L | Purchase (P) | Common Stock | 31,050 | USD 16.15 | USD 501,457 | SEC filing ↗ |
| 2025-11-07 | Spetzler David Baxley | Purchase (P) | Common Stock | 400 | USD 23.85 | USD 9,540 | SEC filing ↗ |
| 2025-11-07 | Denton John Russel | Purchase (P) | Common Stock | 4,184 | USD 24.09 | USD 100,793 | SEC filing ↗ |
| 2025-06-20 | Denton John Russel | Purchase (P) | Common Stock | 7,500 | USD 21.00 | USD 157,500 | SEC filing ↗ |
| 2025-06-20 | Brille Brian J | Purchase (P) | Common Stock | 30,000 | USD 21.00 | USD 630,000 | SEC filing ↗ |
Form 4 evidence
45 transaction lines in the latest 365-day window; 80 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-22 | Denton John Russel | Sale (S) | Common Stock | 7,500 | USD 31.82 | USD 238,650 | SEC filing ↗ |
| 2026-09-17 | Brille Brian J | Sale (S) | Common Stock | 400,000 | USD 30.33 | USD 12,132,000 | SEC filing ↗ |
| 2026-09-17 | Brille Brian J | Option exercise / conversion (M) | Common Stock | 400,000 | USD 2.44 | USD 976,000 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-22 | Denton John Russel | Sale (S) | Common Stock | 7,500 | USD 31.82 | USD 238,650 | SEC filing ↗ |
| 2026-09-17 | Brille Brian J | Sale (S) | Common Stock | 400,000 | USD 30.33 | USD 12,132,000 | SEC filing ↗ |
| 2026-09-17 | Brille Brian J | Option exercise / conversion (M) | Common Stock | 400,000 | USD 2.44 | USD 976,000 | SEC filing ↗ |
| 2026-09-04 | Spetzler David Baxley | Sale (S) | Common Stock | 119,212 | USD 24.76 | USD 2,951,689 | SEC filing ↗ |
| 2026-09-04 | Spetzler David Baxley | Option exercise / conversion (M) | Common Stock | 250,000 | USD 2.44 | USD 610,000 | SEC filing ↗ |
| 2026-09-03 | Spetzler David Baxley | Sale (S) | Common Stock | 478,000 | USD 24.86 | USD 11,882,824 | SEC filing ↗ |
| 2026-09-03 | Spetzler David Baxley | Option exercise / conversion (M) | Common Stock | 1,000,000 | USD 2.44 | USD 2,440,000 | SEC filing ↗ |
| 2026-08-14 | Vacirca Jeff L | Award / grant (A) | Common Stock | 13,192 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-14 | PHILLIPS T DANNY | Award / grant (A) | Common Stock | 13,192 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-14 | Minor Lloyd | Award / grant (A) | Common Stock | 13,192 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-14 | JOHANSEN LAURA I | Award / grant (A) | Common Stock | 13,192 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-14 | HALBERT JON | Award / grant (A) | Common Stock | 13,192 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-14 | Gilliam Joseph E | Award / grant (A) | Common Stock | 13,192 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-14 | Fredrickson David Paul | Award / grant (A) | Common Stock | 13,192 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-14 | CASTLEMAN PETER M | Award / grant (A) | Common Stock | 13,192 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-29 | POSTE GEORGE | Award / grant (A) | Common Stock | 1,600 | USD 15.62 | USD 24,992 | SEC filing ↗ |
| 2026-05-29 | Knowles Jonathan Kenneth Charles | Award / grant (A) | Common Stock | 1,600 | USD 15.62 | USD 24,992 | SEC filing ↗ |
| 2026-05-15 | HALBERT JON | Purchase (P) | Common Stock | 68,000 | USD 14.56 | USD 990,080 | SEC filing ↗ |
| 2026-05-15 | Spetzler David Baxley | Tax withholding (F) | Common Stock | 13,856 | USD 15.25 | USD 211,304 | SEC filing ↗ |
| 2026-05-15 | Power Luke Thomas | Tax withholding (F) | Common Stock | 9,771 | USD 15.25 | USD 149,008 | SEC filing ↗ |
| 2026-05-15 | HALBERT DAVID D | Tax withholding (F) | Common Stock | 40,712 | USD 15.25 | USD 620,858 | SEC filing ↗ |
| 2026-05-15 | Denton John Russel | Tax withholding (F) | Common Stock | 6,047 | USD 15.25 | USD 92,217 | SEC filing ↗ |
| 2026-05-15 | Brille Brian J | Tax withholding (F) | Common Stock | 13,987 | USD 15.25 | USD 213,302 | SEC filing ↗ |
| 2026-05-11 | Vacirca Jeff L | Purchase (P) | Common Stock | 31,050 | USD 16.15 | USD 501,457 | SEC filing ↗ |
| 2026-03-06 | Spetzler David Baxley | Award / grant (A) | Common Stock | 83,162 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-06 | Power Luke Thomas | Award / grant (A) | Common Stock | 63,971 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-06 | HALBERT DAVID D | Award / grant (A) | Common Stock | 320,112 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-06 | Denton John Russel | Award / grant (A) | Common Stock | 63,971 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-06 | Brille Brian J | Award / grant (A) | Common Stock | 83,162 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-02-26 | Minor Lloyd | Award / grant (A) | Common Stock | 2,492 | USD 20.06 | USD 49,990 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | CAI |
| CIK | 0002019410 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 8071 Services-Medical Laboratories |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 80 transaction lines from 2025-02-27 to 2026-09-22 6 P purchase lines · 7 S sale lines · 67 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.